In 14 consecutive 9- to 18-year-old patients with preductal aortic coarctation and isthmic hypoplasia, we resected the coarctation ridge through a longitudinal aortotomy and widened the aorta with an in situ left internal mammary artery flap. This technique resulted in no surgical complications. At 6-month follow-up examination, the average decrease in systolic pressure across the repair was 8.8 mmHg; all patients showed a clear reduction in arterial hypertension at rest and during exercise. Femoral pulses were easily palpable in all cases. Angiography and magnetic resonance imaging showed no aneurysm formation. The narrowest internal diameter of repair was 88% +/- 12% (mean +/- SD) of the diameter of the aortic arch. The internal mammary artery flap technique, which reflects the basic principle of autogenous arterial grafting in situ, allows appropriate circumferential widening of the aorta in many patients with coarctation and hypoplasia of the aortic isthmus involving delayed repair. This procedure should be considered when the internal mammary artery is of good caliber and quality and the anatomic conditions are not ideal for classic end-to-end anastomotic repair.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC325011 | PMC |
World Neurosurg
January 2025
Department of Laboratory, The People's Hospital of Wuyuan County, Shangrao, China. Electronic address:
Background: This retrospective study aimed to identify key prognostic factors for patients with traumatic intracranial hemorrhage (TICH) and develop a comprehensive nomogram for prognostic assessment.
Methods: A retrospective study was carried out on TICH patients at a single-center hospital from October 2013 to September 2022. Using logistic regression analyses, key prognostic factors for TICH were identified and used to create a predictive nomogram model.
JCO Glob Oncol
January 2025
Department of Surgery, American University of Beirut, Beirut, Lebanon.
Purpose: We aimed to evaluate the impact of COVID-19 on breast cancer care in terms of the stage at presentation, treatment delays, and follow-up in a tertiary care center in Lebanon.
Materials And Methods: This retrospective study compared patients with breast cancer who presented to a tertiary care center in Lebanon before (September 2019-December 2019) and during (September 2020-December 2020) the COVID-19 pandemic. We extracted data from the electronic medical records of patients with breast cancer who had their initial presentation, were under treatment, or were on follow-up during our period of interest.
JNCI Cancer Spectr
January 2025
Division of General Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Background: Early palliative care is associated with better outcomes for patients with advanced-stage cancers. Using a novel data linkage, we assessed outpatient palliative care use before death and its association with end-of-life care intensity and variation across eight provider networks.
Methods: We linked Massachusetts Cancer Registry and the All-Payer Claims Database for individuals with commercial insurance, Medicaid or Medicare Advantage diagnosed with colorectal, lung, prostate, and breast cancers from 2010 through 2013 who died by December 31, 2014.
BMC Cancer
January 2025
Institute for Clinical Epidemiology and Biometry, Julius-Maximilian University Würzburg, Würzburg, Germany.
Background: The treatment of metastatic breast cancer (mBC) focuses on prolonging patient survival, providing adequate symptom management, and maintaining quality of life (QoL). This includes supportive therapy to prevent or treat potential side effects and handle comorbidities. The combination of mBC therapy, supportive therapy, and treatment for comorbidities increases the risk for polypharmacy, potential drug-drug interactions (pDDI), potentially inappropriate medication (PIM), and potentially missing drugs (pMD).
View Article and Find Full Text PDFNPJ Breast Cancer
January 2025
Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Cancer disrupts intratumoral innate-adaptive immune crosstalk, but how the systemic immune landscape evolves during breast cancer progression remains unclear. We profiled circulating immune cells in stage I-III and stage IV triple-negative breast cancer (TNBC) patients and healthy donors (HDs). Metastatic TNBC (mTNBC) patients had reduced T cells, dendritic cells, and differentiated B cells compared to non-metastatic TNBC patients and HDs, partly linked to prior chemotherapy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!